Clinical trial
Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone…
NCT00160316 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00160316 |
|---|---|
| Title | Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination |
| Official title | Endometrial Safety of a Low Dose Continuous Combined 17 -Estradiol/Dydrogesterone Hormone Replacement Regimen (E2 0.5 mg/ D 2.5 mg) in Postmenopausal Women - A One-Year, Open Label, Multi-Center Study |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postmenopause |
| Intervention type | Drug |
| Interventions | 0.5 Mg Estradiol and 2.5 Mg Dydrogesterone |
| Enrollment | 454 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 12, 2008 |
| Countries | Croatia, Poland, Romania, Ukraine |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: